Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 514977

The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients


Pavićević, Radomir; Bialk, Peter; Bubanović, Gordana; Krajna, Ana; Samaržija, Miroslav; Pavićević, Lukrecija
The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients // ATS 97th International Conference Abstract Book
New York (NY): American Thoracic Society (ATS), 2001. str. 485-485 (predavanje, nije recenziran, sažetak, znanstveni)


CROSBI ID: 514977 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients

Autori
Pavićević, Radomir ; Bialk, Peter ; Bubanović, Gordana ; Krajna, Ana ; Samaržija, Miroslav ; Pavićević, Lukrecija

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
ATS 97th International Conference Abstract Book / - New York (NY) : American Thoracic Society (ATS), 2001, 485-485

Skup
ATS 97th International Conference

Mjesto i datum
San Francisco (CA), Sjedinjene Američke Države, 18.05.2001. - 23.05.2001

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Nije recenziran

Ključne riječi
CYFRA 21-1; lung cancer

Sažetak
The clinical application of cytokeratin marker CYFRA 21-1 was standardized on 2000 patients. In all patients the start value of CYFRA 21-1 was determined before therapy (Roche Diagnostics). Tumor marker CYFRA 21-1 was assessed longitudinally 1 to 36 months after the therapy, or before the next therapy. One to three months after the surgical treatment in 87% of the patients the marker values decreased to the healthy population level, depending on the therapy and TNM stage (p<0.0001). The …

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinika za plućne bolesti "Jordanovac"


Citiraj ovu publikaciju:

Pavićević, Radomir; Bialk, Peter; Bubanović, Gordana; Krajna, Ana; Samaržija, Miroslav; Pavićević, Lukrecija
The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients // ATS 97th International Conference Abstract Book
New York (NY): American Thoracic Society (ATS), 2001. str. 485-485 (predavanje, nije recenziran, sažetak, znanstveni)
Pavićević, R., Bialk, P., Bubanović, G., Krajna, A., Samaržija, M. & Pavićević, L. (2001) The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients. U: ATS 97th International Conference Abstract Book.
@article{article, author = {Pavi\'{c}evi\'{c}, Radomir and Bialk, Peter and Bubanovi\'{c}, Gordana and Krajna, Ana and Samar\v{z}ija, Miroslav and Pavi\'{c}evi\'{c}, Lukrecija}, year = {2001}, pages = {485-485}, keywords = {CYFRA 21-1, lung cancer}, title = {The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients}, keyword = {CYFRA 21-1, lung cancer}, publisher = {American Thoracic Society (ATS)}, publisherplace = {San Francisco (CA), Sjedinjene Ameri\v{c}ke Dr\v{z}ave} }
@article{article, author = {Pavi\'{c}evi\'{c}, Radomir and Bialk, Peter and Bubanovi\'{c}, Gordana and Krajna, Ana and Samar\v{z}ija, Miroslav and Pavi\'{c}evi\'{c}, Lukrecija}, year = {2001}, pages = {485-485}, keywords = {CYFRA 21-1, lung cancer}, title = {The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients}, keyword = {CYFRA 21-1, lung cancer}, publisher = {American Thoracic Society (ATS)}, publisherplace = {San Francisco (CA), Sjedinjene Ameri\v{c}ke Dr\v{z}ave} }




Contrast
Increase Font
Decrease Font
Dyslexic Font